Tags

Type your tag names separated by a space and hit enter

Hydration and dehydration behavior of aspartame hemihydrate.
J Pharm Sci. 1998 Apr; 87(4):508-13.JP

Abstract

Previous studies have shown that aspartame in the solid state can exist as a hemihydrate which occurs in two different polymorphic forms (I and II). The present work shows that equilibration of either hemihydrate at 25 degrees C with water vapor at relative humidities > or = 58% or with liquid water produces a 2.5-hydrate. Upon subjecting each of these crystalline hydrates to increasing temperature, the same crystalline anhydrate is formed which thermally cyclizes at a higher temperature to form the known compound 3-(carboxymethyl)-6-benzyl-2,5-dioxopiperazine. The activation energy of the cyclization reaction appears to depend on the degree of crystallinity of the anhydrate that is formed at a lower temperature. On increasing the temperature of the 2.5-hydrate, a hemihydrate intervenes before the anhydrate is formed. This intervening hemihydrate is similar to the commercial form (II) of aspartame hemihydrate but exhibits greater amorphous character. The techniques employed were Karl Fischer titrimetry, powder X-ray diffractometry, differential scanning calorimetry, thermogravimetric analysis, solid-state 13C nuclear magnetic resonance spectroscopy, and Fourier transform infrared absorption spectroscopy.

Authors+Show Affiliations

Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis 55455-0343, USA.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

9548906

Citation

Leung, S S., et al. "Hydration and Dehydration Behavior of Aspartame Hemihydrate." Journal of Pharmaceutical Sciences, vol. 87, no. 4, 1998, pp. 508-13.
Leung SS, Padden BE, Munson EJ, et al. Hydration and dehydration behavior of aspartame hemihydrate. J Pharm Sci. 1998;87(4):508-13.
Leung, S. S., Padden, B. E., Munson, E. J., & Grant, D. J. (1998). Hydration and dehydration behavior of aspartame hemihydrate. Journal of Pharmaceutical Sciences, 87(4), 508-13.
Leung SS, et al. Hydration and Dehydration Behavior of Aspartame Hemihydrate. J Pharm Sci. 1998;87(4):508-13. PubMed PMID: 9548906.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hydration and dehydration behavior of aspartame hemihydrate. AU - Leung,S S, AU - Padden,B E, AU - Munson,E J, AU - Grant,D J, PY - 1998/4/21/pubmed PY - 2000/7/19/medline PY - 1998/4/21/entrez SP - 508 EP - 13 JF - Journal of pharmaceutical sciences JO - J Pharm Sci VL - 87 IS - 4 N2 - Previous studies have shown that aspartame in the solid state can exist as a hemihydrate which occurs in two different polymorphic forms (I and II). The present work shows that equilibration of either hemihydrate at 25 degrees C with water vapor at relative humidities > or = 58% or with liquid water produces a 2.5-hydrate. Upon subjecting each of these crystalline hydrates to increasing temperature, the same crystalline anhydrate is formed which thermally cyclizes at a higher temperature to form the known compound 3-(carboxymethyl)-6-benzyl-2,5-dioxopiperazine. The activation energy of the cyclization reaction appears to depend on the degree of crystallinity of the anhydrate that is formed at a lower temperature. On increasing the temperature of the 2.5-hydrate, a hemihydrate intervenes before the anhydrate is formed. This intervening hemihydrate is similar to the commercial form (II) of aspartame hemihydrate but exhibits greater amorphous character. The techniques employed were Karl Fischer titrimetry, powder X-ray diffractometry, differential scanning calorimetry, thermogravimetric analysis, solid-state 13C nuclear magnetic resonance spectroscopy, and Fourier transform infrared absorption spectroscopy. SN - 0022-3549 UR - https://www.unboundmedicine.com/medline/citation/9548906/Hydration_and_dehydration_behavior_of_aspartame_hemihydrate_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0022-3549(15)50545-5 DB - PRIME DP - Unbound Medicine ER -